Spots Global Cancer Trial Database for ropidoxuridine

Every month we try and update this database with for ropidoxuridine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer	NCT04406857	Locally Advance... Rectal Adenocar... Stage II Rectal... Stage III Recta...	Capecitabine Radiation Thera... Ropidoxuridine	18 Years -	National Cancer Institute (NCI)
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer	NCT04406857	Locally Advance... Rectal Adenocar... Stage II Rectal... Stage III Recta...	Capecitabine Radiation Thera... Ropidoxuridine	18 Years -	National Cancer Institute (NCI)
Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases	NCT02993146	Hematopoietic a... Malignant Solid... Metastatic Mali...	Laboratory Biom... Pharmacological... Quality-of-Life... Ropidoxuridine Whole-Brain Rad...	18 Years -	National Cancer Institute (NCI)
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy	NCT02381561	Advanced Bile D... Stage II Esopha... Stage II Pancre... Stage IIA Esoph... Stage IIA Pancr... Stage IIB Esoph... Stage IIB Pancr... Stage III Colon... Stage III Esoph... Stage III Gastr... Stage III Liver... Stage III Pancr... Stage III Recta... Stage III Small... Stage IIIA Colo... Stage IIIA Esop... Stage IIIA Gast... Stage IIIA Rect... Stage IIIA Smal... Stage IIIB Colo... Stage IIIB Esop... Stage IIIB Gast... Stage IIIB Rect... Stage IIIB Smal... Stage IIIC Colo... Stage IIIC Esop... Stage IIIC Gast... Stage IIIC Rect... Stage IV Colon ... Stage IV Esopha... Stage IV Gastri... Stage IV Liver ... Stage IV Pancre... Stage IV Rectal... Stage IV Small ... Stage IVA Colon... Stage IVA Liver... Stage IVA Recta... Stage IVB Colon... Stage IVB Liver... Stage IVB Recta...	Intensity-Modul... Laboratory Biom... Pharmacological... Ropidoxuridine	18 Years -	National Cancer Institute (NCI)
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy	NCT02381561	Advanced Bile D... Stage II Esopha... Stage II Pancre... Stage IIA Esoph... Stage IIA Pancr... Stage IIB Esoph... Stage IIB Pancr... Stage III Colon... Stage III Esoph... Stage III Gastr... Stage III Liver... Stage III Pancr... Stage III Recta... Stage III Small... Stage IIIA Colo... Stage IIIA Esop... Stage IIIA Gast... Stage IIIA Rect... Stage IIIA Smal... Stage IIIB Colo... Stage IIIB Esop... Stage IIIB Gast... Stage IIIB Rect... Stage IIIB Smal... Stage IIIC Colo... Stage IIIC Esop... Stage IIIC Gast... Stage IIIC Rect... Stage IV Colon ... Stage IV Esopha... Stage IV Gastri... Stage IV Liver ... Stage IV Pancre... Stage IV Rectal... Stage IV Small ... Stage IVA Colon... Stage IVA Liver... Stage IVA Recta... Stage IVB Colon... Stage IVB Liver... Stage IVB Recta...	Intensity-Modul... Laboratory Biom... Pharmacological... Ropidoxuridine	18 Years -	National Cancer Institute (NCI)
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter	NCT06359379	Glioblastoma, I...	Ropidoxuridine	18 Years -	Shuttle Pharmaceuticals, Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: